Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts)
QFRD213385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
129,544.00
Year-over-Year Change
20.35%
Date Range
10/1/2000 - 4/1/2025
Summary
This economic indicator tracks trade accounts and notes receivable for U.S. pharmaceutical corporations, providing insight into the financial health and credit dynamics of the pharmaceutical sector. It measures the value of outstanding receivables, which reflects companies' sales, credit terms, and potential cash flow risks.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the net receivables for pharmaceutical companies, indicating their sales performance and credit management strategies. Economists use this metric to assess sector liquidity, credit risk, and overall financial performance of pharmaceutical firms.
Methodology
Data is collected through quarterly financial reports submitted by pharmaceutical corporations, aggregated and processed by the U.S. Federal Reserve.
Historical Context
This indicator is used by financial analysts, investors, and policymakers to evaluate the economic performance and credit conditions in the pharmaceutical industry.
Key Facts
- Measures net trade accounts for U.S. pharmaceutical corporations
- Indicates sector financial health and credit management
- Provides insights into pharmaceutical company sales performance
FAQs
Q: What does this economic indicator measure?
A: It tracks trade accounts and notes receivable for U.S. pharmaceutical corporations, showing the value of outstanding sales credits.
Q: Why are pharmaceutical receivables important?
A: They provide insights into the financial health, sales performance, and credit management of pharmaceutical companies.
Q: How is this data collected?
A: The data is gathered from quarterly financial reports submitted by pharmaceutical corporations and processed by the U.S. Federal Reserve.
Q: How do investors use this information?
A: Investors analyze this trend to assess the financial stability and performance potential of pharmaceutical companies.
Q: How often is this data updated?
A: The data is typically updated quarterly, reflecting the most recent financial reporting period for pharmaceutical corporations.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Petroleum and Coal Products: Trade Accounts and Trade Notes Payable
QFR306324USNO
Quarterly Financial Report: U.S. Corporations: Iron, Steel, and Ferroalloys: Inventories
QFR214371USNO
Quarterly Financial Report: U.S. Corporations: Transportation Equipment: Interest Expense
QFR105TRAUSNO
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Assets
QFR223385USNO
Quarterly Financial Report: U.S. Corporations: Transportation Equipment: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301TRAUSNO
Quarterly Financial Report: U.S. Corporations: All Professional and Technical Services, Except Legal Services: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319PTSUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts) [QFRD213385USNO], retrieved from FRED.
Last Checked: 8/1/2025